Insider Trading Tracker: Live US Stock Disclosures & Insider Buying from Jun 30, 2026 to Jul 14, 2026

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 200 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Diageo PLC (ADR)	John Alexander Manzoni	Non-Executive Director,Chairman	Purchase of securities on an exchange or from another person at price $ 15.03 per share.	10 Jul 2026	436	9,252 (0%)	0%	15.0	6,553	Ords 0.29p
MarketAxess Holdings Inc	Scott Pintoff	General Counsel and Secretary	Sale of securities on an exchange or to another person at price $ 115.12 per share.	10 Jul 2026	100	11,686 (0%)	0%	115.1	11,512	Common Stock, par value $0.003 per share
TruBridge Inc Board Meeting	Damien Leonard	Director	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	2,130,000	0 (0%)	14%	26.3	55,912,500	Common stock, par value $0.001 per share ("Common Stock")
TruBridge Inc Board Meeting	Andris Upitis	Director	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	1,114,178	0 (0%)	7%	26.3	29,247,173	Common Stock
TruBridge Inc Board Meeting	Damien Leonard	Director	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	850,000	0 (0%)	5%	26.3	22,312,500	Common Stock
PSQ Holdings Inc (Class A) Split High Loss High Volume	Blake Masters	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	258,929	442,827	-		0	Class A Common Stock, par value $0.0001 per share
PSQ Holdings Inc (Class A) Split High Loss High Volume	Caitlin Long	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	125,000	125,000	-		0	Class A Common Stock, par value $0.0001 per share
PSQ Holdings Inc (Class A) Split High Loss High Volume	Davis Pilot	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	125,000	272,514	-		0	Class A Common Stock, par value $0.0001 per share
PSQ Holdings Inc (Class A) Split High Loss High Volume	James Rinn	Director, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	125,000	254,864	-		0	Class A Common Stock, par value $0.0001 per share
PSQ Holdings Inc (Class A) Split High Loss High Volume	Donald J. Trump	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	125,000	822,403	-		0	Class A Common Stock, par value $0.0001 per share
PSQ Holdings Inc (Class A) Split High Loss High Volume	Willie Langston	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	125,000	521,205	-		0	Class A Common Stock, par value $0.0001 per share
TruBridge Inc Board Meeting	Christopher L. Fowler	Director, President and CEO	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	120,486	0 (0%)	0%	26.3	3,162,758	Common Stock
Personalis Inc High Gain High Volume	Christopher Hall	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 15.08 per share.	09 Jul 2026	100,000	235,986 (0%)	0%	15.1	1,508,000	Common Stock
Personalis Inc High Gain High Volume	Christopher Hall	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share.	09 Jul 2026	100,000	335,986 (1%)	0%	1.6	161,000	Common Stock
Abeona Therapeutics Inc	Vishwas Seshadri	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 6.96 per share.	09 Jul 2026	67,971	1,306,108 (1%)	0%	7.0	473,330	Common Stock
Personalis Inc High Gain High Volume	Christopher Hall	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	66,667	133,333	-		-	Stock Option (right to buy)
TruBridge Inc Board Meeting	Michael Daughton	Chief Business Officer	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	59,315	0 (0%)	0%	26.3	1,557,019	Common Stock
TruBridge Inc Board Meeting	Glenn P. Tobin	Director	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	50,687	0 (0%)	0%	26.3	1,330,534	Common Stock
TruBridge Inc Board Meeting	Vinay Bassi	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	39,992	0 (0%)	0%	26.3	1,049,790	Common Stock
TruBridge Inc Board Meeting	Regina M. Benjamin	Director	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	38,687	0 (0%)	0%	26.3	1,015,534	Common Stock
Personalis Inc High Gain High Volume	Christopher Hall	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	33,333	0	-		-	Stock Option (right to buy)
TruBridge Inc Board Meeting	Christopher T. Hjelm	Director	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	31,591	0 (0%)	0%	26.3	829,264	Common Stock
Abeona Therapeutics Inc	Joseph W. Vazzano	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 6.96 per share.	09 Jul 2026	24,880	493,557 (0%)	0%	7.0	173,257	Common Stock
TruBridge Inc Board Meeting	Mark V. Anquillare	Director	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	21,554	0 (0%)	0%	26.3	565,793	Common Stock
Alector Inc	Grace Wong-Sarad	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	20,000	115,461 (0%)	0%		0	Common Stock
GBank Fin Holdings Inc	Jeffrey K Newgard	President/CEO (GBank)	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	20,000	20,000	-		0	Common Stock
TruBridge Inc Board Meeting	David B. Harse	General Manager Patient Care	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	16,888	0 (0%)	0%	26.3	443,310	Common Stock
TruBridge Inc Board Meeting	Christopher L. Fowler	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	09 Jul 2026	16,286	120,486 (0%)	0%		0	Common Stock
Abeona Therapeutics Inc	Madhav Vasanthavada	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 6.96 per share.	09 Jul 2026	12,606	290,623 (0%)	0%	7.0	87,784	Common Stock
TruBridge Inc Board Meeting	Kevin Plessner	General Counsel	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	12,460	0 (0%)	0%	26.3	327,075	Common Stock
Abeona Therapeutics Inc	Brendan M. O'Malley	SVP, Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 6.96 per share.	09 Jul 2026	12,050	427,953 (0%)	0%	7.0	83,913	Common Stock
TruBridge Inc Board Meeting	Vinay Bassi	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	09 Jul 2026	10,507	39,992 (0%)	0%		0	Common Stock
Sonoma Pharma Inc	Amy M. Trombly	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	10,000	52,185	-		-	Restricted Stock Units
Sonoma Pharma Inc	John G. Mclaughlin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	10,000	30,001	-		-	Stock option (right to buy)
Sonoma Pharma Inc	Jerome J. Dvonch	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	10,000	44,391	-		-	Restricted Stock Units
Sonoma Pharma Inc	Philippe Weigerstorfer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	10,000	30,001	-		-	Stock option (right to buy)
Sonoma Pharma Inc	Vanessa Jacoby	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	10,000	20,000	-		-	Stock option (right to buy)
UroGen Pharma Ltd	Mark P. Schoenberg	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 40.00 per share.	09 Jul 2026	10,000	119,763 (0%)	0%	40	400,000	Ordinary Shares
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share.	09 Jul 2026	9,500	50,013 (0%)	0%	135.4	1,286,490	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	9,500	30,218	-		-	Stock Option
TruBridge Inc Board Meeting	Michael Daughton	Chief Business Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	09 Jul 2026	8,749	59,315 (0%)	0%		0	Common Stock
TruBridge Inc Board Meeting	Merideth Wilson	Financial Health GM	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	7,734	0 (0%)	0%	26.3	203,018	Common Stock
Sonoma Pharma Inc	Poggetto John Dal	Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	7,500	32,750	-		-	Restricted Stock Units
Planet Labs PBC (Class A)	Carl Bass	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	6,479	403,665	-		0	Class A Common Stock
Planet Labs PBC (Class A)	Gary B. Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	6,479	38,947	-		0	Class A Common Stock
Planet Labs PBC (Class A)	Kristen O. Robinson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	6,479	43,586	-		0	Class A Common Stock
Planet Labs PBC (Class A)	Ita M. Brennan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	6,479	259,137	-		0	Class A Common Stock
Planet Labs PBC (Class A)	Vijaya Gadde	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	6,479	256,648	-		0	Class A Common Stock
Planet Labs PBC (Class A)	Scott Reese	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	6,479	15,286	-		0	Class A Common Stock
Planet Labs PBC (Class A)	John W. Raymond	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	6,479	50,087	-		0	Class A Common Stock
Insmed Inc	William H. Lewis	Director, Chair and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.46 per share.	09 Jul 2026	6,259	265,317 (0%)	0%	30.5	190,649	Common Stock
Insmed Inc	William H. Lewis	Director, Chair and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	6,259	6,260	-		-	Stock Option (right to buy)
Insmed Inc	William H. Lewis	Director, Chair and CEO	Sale of securities on an exchange or to another person at price $ 116.55 per share.	09 Jul 2026	5,005	264,752 (0%)	0%	116.6	583,333	Common Stock
Insmed Inc	William H. Lewis	Director, Chair and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	4,440	4,440	-		-	Stock Option (right to buy)
Insmed Inc	William H. Lewis	Director, Chair and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.16 per share.	09 Jul 2026	4,440	269,757 (0%)	0%	17.2	76,190	Common Stock
Powell Industries Inc	Brett A. Cope	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 241.55 per share.	09 Jul 2026	4,440	517,233 (4%)	0%	241.6	1,072,482	Common Stock
TruBridge Inc Board Meeting	Andris Upitis	Director	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	4,376	0 (0%)	0%	26.3	114,870	Common Stock
TruBridge Inc Board Meeting	Jerry G. Canada	Director	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	4,376	0 (0%)	0%	26.3	114,870	Common Stock
TruBridge Inc Board Meeting	Merideth Wilson	Financial Health GM	Sale or transfer of securities back to the company at price $ 0.00 per share.	09 Jul 2026	4,308	7,734 (0%)	0%		0	Common Stock
TruBridge Inc Board Meeting	David B. Harse	General Manager Patient Care	Sale or transfer of securities back to the company at price $ 0.00 per share.	09 Jul 2026	4,203	16,888 (0%)	0%		0	Common Stock
Insmed Inc	William H. Lewis	Director, Chair and CEO	Sale of securities on an exchange or to another person at price $ 118.52 per share.	09 Jul 2026	3,359	259,058 (0%)	0%	118.5	398,109	Common Stock
Sunrun Inc	Maria Barak	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 12.17 per share.	09 Jul 2026	3,278	90,033 (0%)	0%	12.2	39,893	Common Stock
Farmers & Merchants Bancorp Inc	Andrew J. Briggs	Director	Sale of securities on an exchange or to another person at price $ 29.42 per share.	09 Jul 2026	3,000	132,550 (1%)	0%	29.4	88,260	Common Stock
Farmers & Merchants Bancorp Inc	Andrew J. Briggs	Director	Sale of securities on an exchange or to another person at price $ 29.52 per share.	09 Jul 2026	3,000	129,550 (1%)	0%	29.5	88,560	Common Stock
Planet Labs PBC (Class A)	Carl Bass	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	2,880	406,545	-		0	Class A Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 551.03 per share.	09 Jul 2026	2,863	43,722 (0%)	0%	551.0	1,577,611	Common Stock
Casey`s General Stores Inc	Ena Williams	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 833.69 per share.	09 Jul 2026	2,800	21,969 (0%)	0%	833.7	2,334,332	Common Stock
Culp Inc	Robert G. Culp	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 3.33 per share.	09 Jul 2026	2,768	129,085 (1%)	0%	3.3	9,217	Common Stock
Planet Labs PBC (Class A)	Ita M. Brennan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	2,736	261,873	-		0	Class A Common Stock
Insmed Inc	William H. Lewis	Director, Chair and CEO	Sale of securities on an exchange or to another person at price $ 117.62 per share.	09 Jul 2026	2,335	262,417 (0%)	0%	117.6	274,643	Common Stock
Planet Labs PBC (Class A)	Gary B. Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	2,160	41,107	-		0	Class A Common Stock
Planet Labs PBC (Class A)	Scott Reese	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	2,160	17,446	-		0	Class A Common Stock
TruBridge Inc Board Meeting	Kevin Plessner	General Counsel	Sale or transfer of securities back to the company at price $ 0.00 per share.	09 Jul 2026	2,150	12,460 (0%)	0%		0	Common Stock
TruBridge Inc Board Meeting	Vita MacIntyre	Controller	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	1,934	0 (0%)	0%	26.3	50,768	Common Stock
Guidewire Software Inc	James Winston King	Chief Admin Officer, Gen Couns	Sale of securities on an exchange or to another person at price $ 130.64 per share.	09 Jul 2026	1,684	30,018 (0%)	0%	130.6	219,998	Common Stock
H.B. Fuller Co	Joao Magalhaes	Sr. VP, Engineering Adhesives	Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.10 per share.	09 Jul 2026	1,658	5,523 (0%)	0%	50.1	83,066	Common Stock
H.B. Fuller Co	Joao Magalhaes	Sr. VP, Engineering Adhesives	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	1,658	0	-		-	Employee Stock Option (Right-to-Buy)
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 552.38 per share.	09 Jul 2026	1,648	42,074 (0%)	0%	552.4	910,323	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 549.01 per share.	09 Jul 2026	1,536	48,037 (0%)	0%	549.0	843,273	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 550.12 per share.	09 Jul 2026	1,452	46,585 (0%)	0%	550.1	798,780	Common Stock
Ally Fin Inc Results Board Meeting	Thomas P. Gibbons	Director	Grant, award, or other acquisition of securities at price $ 45.95 per share.	09 Jul 2026	1,034	26,062 (0%)	0%	45.9	47,512	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 553.29 per share.	09 Jul 2026	801	41,273 (0%)	0%	553.3	443,185	Common Stock
TruBridge Inc Board Meeting	Vita MacIntyre	Controller	Sale or transfer of securities back to the company at price $ 0.00 per share.	09 Jul 2026	753	1,934 (0%)	0%		0	Common Stock
Ally Fin Inc Results Board Meeting	David Reilly	Director	Grant, award, or other acquisition of securities at price $ 45.95 per share.	09 Jul 2026	708	36,770 (0%)	0%	46.0	32,533	Common Stock
United Therapeutics Corp	Jan Malcolm	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	650	0	-		-	Restricted Stock Unit
United Therapeutics Corp	Jan Malcolm	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	650	775 (0%)	0%		0	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 554.22 per share.	09 Jul 2026	640	40,633 (0%)	0%	554.2	354,704	Common Stock
Domino's Pizza	Kelly E. Garcia	EVP, Chief Tech & Data Ofcr	Sale of securities on an exchange or to another person at price $ 297.01 per share.	09 Jul 2026	487	9,351 (0%)	0%	297.0	144,644	Common Stock, $0.01 par value
Domino's Pizza	Kelly E. Garcia	EVP, Chief Tech & Data Ofcr	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jul 2026	487	0	-		-	Option to Purchase Common Stock
Domino's Pizza	Kelly E. Garcia	EVP, Chief Tech & Data Ofcr	Exercise or conversion of derivative security received from the company (such as an option) at price $ 136.89 per share.	09 Jul 2026	487	9,838 (0%)	0%	136.9	66,665	Common Stock, $0.01 par value
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 548.16 per share.	09 Jul 2026	440	49,573 (0%)	0%	548.2	241,189	Common Stock
Seacoast Banking Corp Of Florida	H. Gilbert Culbreth	Director	Grant, award, or other acquisition of securities at price $ 31.66 per share.	09 Jul 2026	390	49,982 (0%)	0%	31.7	12,347	Common Stock
United Therapeutics Corp	Jan Malcolm	Director	Sale of securities on an exchange or to another person at price $ 550.59 per share.	09 Jul 2026	325	450 (0%)	0%	550.6	178,942	Common Stock
Lowe's	Richard W. Dreiling	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	258	19,647	-		-	Phantom Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Sale of securities on an exchange or to another person at price $ 555.77 per share.	09 Jul 2026	120	40,513 (0%)	0%	555.8	66,692	Common Stock
Lowe's	Brian C. Rogers	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	117	5,687	-		-	Phantom Stock
Lowe's	Laurie Z. Douglas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	70	4,899	-		-	Phantom Stock
Barings Corporate Investors Results	Christina Emery	President	Other type of transaction at price $ 0.00 per share.	09 Jul 2026	43	6,938	-		-	Barings Non-Qualified Thrift Plan
Valvoline Inc	Lori Ann Flees	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jul 2026	25	15,602	-		-	Deferred Stock Units
Citizens Fin Services Inc	R. Joseph Landy	Director	Gift of securities by or to the insider at price $ 0.00 per share.	09 Jul 2026	20	28,041 (0%)	0%		0	COMMON CLASS
TruBridge Inc Board Meeting	Christopher L. Fowler	Director, President and CEO	Sale or transfer of securities back to the company at price $ 26.25 per share.	09 Jul 2026	16	0 (0%)	0%	26.3	420	Common Stock
Citizens Fin Services Inc	LeeAnn Gephart	EXECUTIVE VICE PRESIDENT	Sale of securities on an exchange or to another person at price $ 71.53 per share.	09 Jul 2026	15	946 (0%)	0%	71.5	1,073	COMMON CLASS
Amplitude Inc (Class A)	Curtis Liu	Director, Chief Technology Officer, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	08 Jul 2026	175,000	175,000	-		-	Class B Common Stock
Amplitude Inc (Class A)	Curtis Liu	Director, Chief Technology Officer, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	08 Jul 2026	175,000	7,207,208	-		-	Class B Common Stock
Perrigo Co PLC	Charles Atkinson	EVP, General Counsel & Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	123,704	123,704	-		-	Restricted Stock Units
Perrigo Co PLC	Roberto Khoury	EVP and President of CSCI	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	113,101	113,101	-		-	Restricted Stock Units
Medical Properties Trust Inc	Edward K. Aldag	Director, Chairman, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.61 per share.	08 Jul 2026	109,433	6,685,775 (1%)	0%	4.6	504,486	Common stock, par value $0.001
Wrap Tech Inc	John D. Shulman	Director	Purchase of securities on an exchange or from another person at price $ 1.10 per share.	08 Jul 2026	100,000	199,037 (0%)	0%	1.1	110,000	Common Stock
Perrigo Co PLC	Abigail Lennox	EVP and CSO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	84,826	84,826	-		-	Restricted Stock Units
Perrigo Co PLC	David Ball	EVP & CBDO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	70,688	70,688	-		-	Restricted Stock Units
Perrigo Co PLC	Matthew John Winterman	EVP, Supply, Ops, Strategy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	70,688	70,688	-		-	Restricted Stock Units
Perrigo Co PLC	Robert Willis	EVP & CHRO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	60,085	60,085	-		-	Restricted Stock Units
Copart	Diane M. Morefield	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	50,000	0	-		-	Stock Option
Copart	Diane M. Morefield	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.78 per share.	08 Jul 2026	50,000	50,000 (0%)	0%	19.8	988,750	Common Stock
Seres Therapeutics Inc High Loss High Volume	Richard N. Kender	Director, See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	50,000	50,000	-		-	Stock Option (right to buy)
Medical Properties Trust Inc	R. Steven Hamner	Director, Executive Vice President & CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.61 per share.	08 Jul 2026	48,548	3,792,472 (0%)	0%	4.6	223,806	Common stock, par value $0.001
Syndax Pharma Inc Board Meeting	Michael Metzger	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 24.24 per share.	08 Jul 2026	32,375	484,843 (1%)	0%	24.2	784,776	Common Stock
Syndax Pharma Inc Board Meeting	Michael Metzger	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	32,375	0	-		-	Stock Option (Right to buy)
Syndax Pharma Inc Board Meeting	Michael Metzger	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.38 per share.	08 Jul 2026	32,375	517,218 (1%)	0%	6.4	206,553	Common Stock
Seres Therapeutics Inc High Loss High Volume	Matthew Henn	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	25,000	25,000	-		-	Stock Option (right to buy)
Bicara Therapeutics Inc	Ryan Cohlhepp	Director, President and COO	Sale of securities on an exchange or to another person at price $ 28.76 per share.	08 Jul 2026	22,833	187,558	-	28.8	656,652	Common Stock
Bicara Therapeutics Inc	Ivan Hyep	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 28.60 per share.	08 Jul 2026	22,757	135,098	-	28.6	650,896	Common Stock
Owlet Inc (Class A)	Kurt Workman	President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.91 per share.	08 Jul 2026	21,001	1,211,079	-	5.9	124,116	Common Stock
Designer Brands Inc (Class A)	Douglas M. Howe	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	20,527	114,904	-		-	Dividend Equivalent Rights
Praxis Precision Medicines Inc	Marcio Souza	Director, Chief Executive Officer	Gift of securities by or to the insider at price $ 0.00 per share.	08 Jul 2026	20,521	56,495	-		0	Common Stock
Hormel Foods Dividend	Gary C. Bhojwani	Director	Sale of securities on an exchange or to another person at price $ 24.51 per share.	08 Jul 2026	20,200	32,002 (0%)	0%	24.5	495,159	Common Stock
Bicara Therapeutics Inc	Ryan Cohlhepp	Director, President and COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share.	08 Jul 2026	18,750	210,391	-	3.8	71,059	Common Stock
Bicara Therapeutics Inc	Ryan Cohlhepp	Director, President and COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	18,750	70,502	-		-	Stock Option (Right to Buy)
Seres Therapeutics Inc High Loss High Volume	Kelly Brady	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	18,750	18,750	-		-	Stock Option (right to buy)
ATI Inc	Kimberly A. Fields	Director, Chair, President and CEO	Sale of securities on an exchange or to another person at price $ 183.50 per share.	08 Jul 2026	15,908	163,187 (0%)	0%	183.5	2,919,118	Common Stock, par value $0.10 per share
Perrigo Co PLC	Matthew John Winterman	EVP, Supply, Ops, Strategy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.52 per share.	08 Jul 2026	15,660	15,660 (0%)	0%	10.5	164,743	Ordinary Shares
Perrigo Co PLC	Matthew John Winterman	EVP, Supply, Ops, Strategy	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	15,660	15,659	-		-	Restricted Stock Units
Designer Brands Inc (Class A)	Jay L. Schottenstein	Director, Executive Chairman, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	15,165	84,277	-		-	Dividend Equivalent Rights
Columbus Mckinnon Corp	Gregory P. Rustowicz	Executive VP Finance, CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	15,072	109,196 (0%)	0%		0	Common Stock
Cellectar Biosciences Inc	Stefan D. Loren	Consultant	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	15,000	15,000	-		-	Stock option (right to buy)
Tempus AI Inc (Class A)	Ryan Fukushima	CEO, Data	Sale of securities on an exchange or to another person at price $ 56.80 per share.	08 Jul 2026	13,984	187,063	-	56.8	794,291	Class A Common Stock
Tempus AI Inc (Class A)	Ryan Fukushima	CEO, Data	Sale of securities on an exchange or to another person at price $ 57.37 per share.	08 Jul 2026	13,686	173,377	-	57.4	785,166	Class A Common Stock
Bicara Therapeutics Inc	Ivan Hyep	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share.	08 Jul 2026	12,500	157,855	-	3.8	47,373	Common Stock
ATI Inc	Kimberly A. Fields	Director, Chair, President and CEO	Sale of securities on an exchange or to another person at price $ 182.66 per share.	08 Jul 2026	11,826	179,095 (0%)	0%	182.7	2,160,137	Common Stock, par value $0.10 per share
National Vision Holdings Inc	Mark Banner	President, Americas Best	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	11,728	49,894	-		-	Restricted Stock Units
National Vision Holdings Inc	Mark Banner	President, Americas Best	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	11,728	29,567 (0%)	0%		-	Common Stock
Bicara Therapeutics Inc	Ivan Hyep	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	11,592	58,992	-		-	Stock Option (Right to Buy)
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	9,500	39,718	-		-	Stock Option
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share.	08 Jul 2026	9,500	50,013 (0%)	0%	135.4	1,286,490	Common Stock
Consolidated Edison	Kirkland B. Andrews	SVP & CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 112.09 per share.	08 Jul 2026	8,524	33,616 (0%)	0%	112.1	955,455	Common Stock
Designer Brands Inc (Class A)	Deborah L. Ferree	Director, V. Chair; Ch Product Off	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	8,221	49,249	-		-	Dividend Equivalent Rights
Perrigo Co PLC	Matthew John Winterman	EVP, Supply, Ops, Strategy	Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.52 per share.	08 Jul 2026	8,175	7,485 (0%)	0%	10.5	86,001	Ordinary Shares
Virco Manufacturing Corp	Douglas A. Virtue	Director, Executive Vice President	Purchase of securities on an exchange or from another person at price $ 6.00 per share.	08 Jul 2026	8,083	888,663 (5%)	0%	6.0	48,474	Common Stock $.01 par value
Quanterix Corp	Myla P. Lai-Goldman	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	8,073	15,041 (0%)	0%		-	Common Stock
Quanterix Corp	Myla P. Lai-Goldman	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	8,073	16,391	-		-	Restricted Stock Unit
Quanterix Corp	Scott Mendel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	8,073	16,391	-		-	Restricted Stock Unit
Quanterix Corp	Scott Mendel	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	8,073	24,056 (0%)	0%		-	Common Stock
JFrog Ltd	Shlomi Ben Haim	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 94.72 per share.	08 Jul 2026	7,755	4,578,637	-	94.7	734,554	Ordinary Shares
Seres Therapeutics Inc High Loss High Volume	Thomas J. DesRosier	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	7,500	7,500	-		-	Stock Option (right to buy)
Seres Therapeutics Inc High Loss High Volume	Marella Thorell	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	7,500	7,500	-		-	Stock Option (right to buy)
Columbus Mckinnon Corp	Gregory P. Rustowicz	Executive VP Finance, CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	6,911	94,124 (0%)	0%		0	Common Stock
Seres Therapeutics Inc High Loss High Volume	Kurt C. Graves	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	6,500	6,500	-		-	Stock Option (right to buy)
Seres Therapeutics Inc High Loss High Volume	Willard H. Dere	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	6,500	6,500	-		-	Stock Option (right to buy)
Seres Therapeutics Inc High Loss High Volume	Dennis A. Ausiello	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	6,500	6,500	-		-	Stock Option (right to buy)
Seres Therapeutics Inc High Loss High Volume	Robert L. Rosiello	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	6,500	6,500	-		-	Stock Option (right to buy)
Seres Therapeutics Inc High Loss High Volume	Eric D. Shaff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	6,500	6,500	-		-	Stock Option (right to buy)
Seres Therapeutics Inc High Loss High Volume	Stephen A. Berenson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	6,500	6,500	-		-	Stock Option (right to buy)
First US Bancshares Inc	Thomas S. Elley	SEVP,CFO,Trea,Ast Sec-FUSB	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	6,300	0	-		-	Stock Option (right to buy)
First US Bancshares Inc	Thomas S. Elley	SEVP,CFO,Trea,Ast Sec-FUSB	Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.71 per share.	08 Jul 2026	6,300	43,080 (0%)	0%	11.7	73,773	Common Stock, $.01 par value
JFrog Ltd	Shlomi Ben Haim	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 93.65 per share.	08 Jul 2026	5,845	4,586,392	-	93.6	547,384	Ordinary Shares
Casey`s General Stores Inc	Stephen P. Bramlage	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 838.16 per share.	08 Jul 2026	5,700	29,677 (0%)	0%	838.2	4,777,512	Common Stock
Digital Turbine Inc	Joshua Kinsell	Chief Accounting Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.50 per share.	08 Jul 2026	5,663	265,276 (0%)	0%	10.5	59,462	Common Stock
BioCardia Inc	Peter Altman	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 0.96 per share.	08 Jul 2026	5,400	361,985 (5%)	0%	1.0	5,208	Common Stock
First US Bancshares Inc	Eric H. Mabowitz	SEVP, CRO, CCO, & CRA Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	5,000	0	-		-	Stock Option (right to buy)
First US Bancshares Inc	Eric H. Mabowitz	SEVP, CRO, CCO, & CRA Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.11 per share.	08 Jul 2026	5,000	23,710 (0%)	0%	14.1	70,550	Common Stock, $.01 par value
Moog Inc (Class A)	Donald R. Fishback	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.65 per share.	08 Jul 2026	5,000	21,853 (0%)	0%	71.6	358,240	Class B Common
Moog Inc (Class A)	Donald R. Fishback	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	5,000	0	-		-	SAR
National Vision Holdings Inc	Mark Banner	President, Americas Best	Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.41 per share.	08 Jul 2026	4,964	24,603 (0%)	0%	19.4	96,351	Common Stock
First US Bancshares Inc	Thomas S. Elley	SEVP,CFO,Trea,Ast Sec-FUSB	Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.95 per share.	08 Jul 2026	4,924	38,156 (0%)	0%	17.0	83,462	Common Stock, $.01 par value
ATI Inc	Kimberly A. Fields	Director, Chair, President and CEO	Sale of securities on an exchange or to another person at price $ 184.34 per share.	08 Jul 2026	4,878	158,309 (0%)	0%	184.3	899,211	Common Stock, par value $0.10 per share
Designer Brands Inc (Class A)	Laura T. Davis	EVP;Pres DSW Designer ShoeWhse	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	4,750	36,969	-		-	Dividend Equivalent Rights
C.H. Robinson Worldwide	Damon J. Lee	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 190.95 per share.	08 Jul 2026	4,698	36,736 (0%)	0%	190.9	897,083	Common Stock
Bicara Therapeutics Inc	Ivan Hyep	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 29.82 per share.	08 Jul 2026	4,413	130,685	-	29.8	131,616	Common Stock
First US Bancshares Inc	Eric H. Mabowitz	SEVP, CRO, CCO, & CRA Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.95 per share.	08 Jul 2026	4,408	19,302 (0%)	0%	17.0	74,716	Common Stock, $.01 par value
Bicara Therapeutics Inc	Ryan Cohlhepp	Director, President and COO	Sale of securities on an exchange or to another person at price $ 29.80 per share.	08 Jul 2026	4,306	183,252	-	29.8	128,302	Common Stock
Kodiak Gas Services Inc Order Win	Cory Roclawski	EVP & CHRO	Sale of securities on an exchange or to another person at price $ 68.36 per share.	08 Jul 2026	4,169	24,662	-	68.4	284,993	Common Stock
DoorDash	Ravi Inukonda	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.66 per share.	08 Jul 2026	4,068	271,538	-	7.7	31,161	Class A Common Stock
DoorDash	Ravi Inukonda	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	4,068	5,081	-		-	Stock Option (right to buy)
DoorDash	Ravi Inukonda	CHIEF FINANCIAL OFFICER	Sale of securities on an exchange or to another person at price $ 193.21 per share.	08 Jul 2026	4,068	252,443	-	193.2	785,978	Class A Common Stock
Medical Properties Trust Inc	Larry H. Portal	SVP, Senior Advisor to the CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.61 per share.	08 Jul 2026	4,048	575,028 (0%)	0%	4.6	18,661	Common stock, par value $0.001
Columbus Mckinnon Corp	Gregory P. Rustowicz	Executive VP Finance, CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.92 per share.	08 Jul 2026	3,928	87,213 (0%)	0%	12.9	50,750	Common Stock
DoorDash	Ravi Inukonda	CHIEF FINANCIAL OFFICER	Sale of securities on an exchange or to another person at price $ 187.64 per share.	08 Jul 2026	3,887	260,046	-	187.6	729,357	Class A Common Stock
Hershey	Mitchell Andrew Arends	SVP Chief Supply Chain Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	3,843	3,843 (0%)	0%		0	Common Stock
First US Bancshares Inc	Eric H. Mabowitz	SEVP, CRO, CCO, & CRA Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	3,600	0	-		-	Stock Option (right to buy)
First US Bancshares Inc	Eric H. Mabowitz	SEVP, CRO, CCO, & CRA Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.71 per share.	08 Jul 2026	3,600	22,902 (0%)	0%	11.7	42,156	Common Stock, $.01 par value
Tempus AI Inc (Class A)	Ryan Fukushima	CEO, Data	Sale of securities on an exchange or to another person at price $ 58.55 per share.	08 Jul 2026	3,477	169,900	-	58.5	203,578	Class A Common Stock
Semtech Corp	Asaf Silberstein	EVP and COO	Sale of securities on an exchange or to another person at price $ 129.94 per share.	08 Jul 2026	3,354	96,862 (0%)	0%	129.9	435,827	Common Stock
Medical Properties Trust Inc	J. Kevin Hanna	Senior VP, Controller & CAO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.61 per share.	08 Jul 2026	3,295	540,204 (0%)	0%	4.6	15,190	Common stock, par value $0.001
Sacks Parente Golf Inc	Brett Hoge	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jul 2026	3,246	3,246	-		-	Series A Convertible Preferred Stock
Medtronic	Matthew R. Walter	SVP, Chief HR Officer	Sale of securities on an exchange or to another person at price $ 83.15 per share.	08 Jul 2026	3,102	35,694 (0%)	0%	83.1	257,931	Ordinary Shares
First US Bancshares Inc	Eric H. Mabowitz	SEVP, CRO, CCO, & CRA Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	3,000	0	-		-	Stock Option (right to buy)
First US Bancshares Inc	Eric H. Mabowitz	SEVP, CRO, CCO, & CRA Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.01 per share.	08 Jul 2026	3,000	23,089 (0%)	0%	10.0	30,030	Common Stock, $.01 par value
First US Bancshares Inc	Beverly J. Dozier	SVP,Secr,Ast Trs-FUSB;SVP-Bank	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.11 per share.	08 Jul 2026	3,000	10,224 (0%)	0%	14.1	42,330	Common Stock, $.01 par value
First US Bancshares Inc	Beverly J. Dozier	SVP,Secr,Ast Trs-FUSB;SVP-Bank	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	08 Jul 2026	3,000	0	-		-	Stock Option (right to buy)
Moog Inc (Class A)	Donald R. Fishback	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 428.40 per share.	08 Jul 2026	2,962	18,891 (0%)	0%	428.4	1,268,921	Class B Common

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made from Jun 30, 2026 to Jul 14, 2026

Monitor US insider transactions and discover insider buying and selling of stocks from Jun 30, 2026 to Jul 14, 2026.

The latest disclosure under SEC insider trading regulations was reported by Diageo plc - ADR., where the revocation of 436 Ords 0.29p of common stock was executed at an average price of $15.0. This transaction was reported to the Securities and Exchange Commission on July 10, 2026.

Screeners based on Insider Trading parameters